These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38346275)

  • 1. Liquid Biopsy Based on Cell-Free DNA and RNA.
    Loy C; Ahmann L; De Vlaminck I; Gu W
    Annu Rev Biomed Eng; 2024 Jul; 26(1):169-195. PubMed ID: 38346275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
    Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
    Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders.
    Drag MH; Kilpeläinen TO
    Physiol Genomics; 2021 Jan; 53(1):33-46. PubMed ID: 33346689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA.
    Zeng H; He B; Yi C; Peng J
    J Genet Genomics; 2018 Apr; 45(4):185-192. PubMed ID: 29706556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
    Deleu J; Schoofs K; Decock A; Verniers K; Roelandt S; Denolf A; Verreth J; De Wilde B; Van Maerken T; De Preter K; Vandesompele J
    Hum Genomics; 2022 Dec; 16(1):73. PubMed ID: 36587211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free RNA Sequencing from Biofluid Samples.
    Zhang L; Liu X; Wang C; Li X; Tian G; Wang W
    Methods Mol Biol; 2023; 2695():9-25. PubMed ID: 37450109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA diagnostics: current and emerging applications in oncology.
    Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
    Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing.
    Han D; Li R; Shi J; Tan P; Zhang R; Li J
    Theranostics; 2020; 10(12):5501-5513. PubMed ID: 32373224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Longing' for the Next Generation of Liquid Biopsy: The Diagnostic Potential of Long Cell-Free DNA in Oncology and Prenatal Testing.
    Yu SCY; Choy LYL; Lo YMD
    Mol Diagn Ther; 2023 Sep; 27(5):563-571. PubMed ID: 37474843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics.
    Song P; Wu LR; Yan YH; Zhang JX; Chu T; Kwong LN; Patel AA; Zhang DY
    Nat Biomed Eng; 2022 Mar; 6(3):232-245. PubMed ID: 35102279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Prenatal Testing Using Circulating DNA and RNA: Advances, Challenges, and Possibilities.
    Moufarrej MN; Bianchi DW; Shaw GM; Stevenson DK; Quake SR
    Annu Rev Biomed Data Sci; 2023 Aug; 6():397-418. PubMed ID: 37196360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free RNA for the liquid biopsy of gastrointestinal cancer.
    Xing S; Zhu Y; You Y; Wang S; Wang H; Ning M; Jin H; Liu Z; Zhang X; Yu C; Lu ZJ
    Wiley Interdiscip Rev RNA; 2023; 14(5):e1791. PubMed ID: 37086051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of modern circulating cell-free DNA diagnostic tools for detection of specific tumour cells in clinical practice.
    Gašperšič J; Videtič Paska A
    Biochem Med (Zagreb); 2020 Oct; 30(3):030504. PubMed ID: 32774122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
    Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
    Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
    [No Abstract]   [Full Text] [Related]  

  • 17. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
    Geeurickx E; Hendrix A
    Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free DNA: Applications in Different Diseases.
    Ranucci R
    Methods Mol Biol; 2019; 1909():3-12. PubMed ID: 30580419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
    Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.